$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > Cabometyx

纳武利尤单抗|最新研究

晚期肾细胞癌患者无进展生存期翻倍!百时美施贵宝Opdivo组合疗法3

纳武利尤单抗|上市信息

欧盟委员会批准Cabometyx联合Opdivo( 纳武利尤单抗)一线治疗晚期肾